[ESES-syndrome in child- and adolescent psychiatry].
OBJECTIVE
The article describes the theoretical background of the diagnosis and therapy of the ESES syndrome.


METHODS
The assessment and treatment of children with ESES in a child-psychiatric setting is shown. The underlying data have been taken from 18 outpatients with or without epileptic seizures.


RESULTS
The early diagnosis of non-specific symptoms and the anti-epileptic treatment probably play an important role in preventing the progression of ultrastructural brain damage. Sultiam is the drug of first preference.
Jung
M
M
Klinik für Kinder- und Jugendpsychiatrie und Psychotherapie Schleswig Hesterberg. m.a.jung@t-online.de
Gabriel
K H
KH
Stolle
D
D
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000927:Anticonvulsants / Q000008:administration & dosage / Q000627:therapeutic use*; D001569:Benzodiazepines; D002648:Child; D002675:Child, Preschool; D000078306:Clobazam; D002658:Developmental Disabilities / Q000209:etiology* / Q000503:physiopathology; D004359:Drug Therapy, Combination; D004569:Electroencephalography; D019305:Epilepsy, Rolandic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D013577:Syndrome; D013843:Thiazines / Q000627:therapeutic use; D016896:Treatment Outcome; D014635:Valproic Acid / Q000627:therapeutic use; D000096926:Benzenesulfonamides
D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D001569:Benzodiazepines; D000078306:Clobazam; D013843:Thiazines; D014635:Valproic Acid; C084593:sulthiame; D000096926:Benzenesulfonamides